iNtRON Biotechnology인트론바이오
048530 · KOSDAQ · ₩048530 · 인트론바이오
₩3,045▼ ₩5 (0.16%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 49.9% | 54.1% | 58.2% | 61.0% | 69.0% | 74.3% |
| Operating margin | −109.1% | −137.6% | −81.6% | −33.7% | −9.5% | 35.1% |
| Net margin | −141.3% | −155.2% | −37.6% | −111.1% | 40.8% | 33.9% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +26.2% | −10.6% | −33.0% | −31.6% | −52.2% | — |
| Operating income growth | −0.1% | −50.8% | −62.0% | −142.4% | −112.9% | — |
| Net income growth | −15.0% | −269.2% | +77.4% | −286.2% | −42.5% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | −15.5% | −11.6% | −2.7% | −10.5% | 5.5% | 9.7% |
| Return on assets | −14.4% | −11.1% | −2.6% | −8.9% | 3.9% | 6.5% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 10.0% | 6.4% | 3.0% | 1.9% | 32.5% | 50.9% |
| Net debt to equity | −34.6% | −53.4% | −56.9% | −58.1% | −24.3% | −60.5% |
| Current ratio | 956.0% | 1,041.1% | 3,806.2% | 7,615.6% | 350.0% | 373.7% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: iNtRON Biotechnology / 인트론바이오 / 048530 / KRX:048530
Source: KRX statistical information